Stocks
Dicerna Pharmaceuticals (DRNA) EBITDA US GAAP (year values) |
|||||||||
| 2016 | 2017 | 2018 | 2019 | 2020 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -58.7 | -59.3 | -87.5 | -119.2 | -110.5 | -118.5 | ||
| Changes by years, y/y, % | -6% | +1% | +48% | +36% | -7% | +12.1% | |||
Dicerna Pharmaceuticals. EBITDA US GAAP, bln rub
Dicerna Pharmaceuticals. EBITDA US GAAP, changes, %
Dicerna Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Dicerna Pharmaceuticals (DRNA) EBITDA US GAAP (quarter values) |
||||||||
| 2020Q3 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -21.3 | -36.0 | -29.1 | -38.6 | -14.8 | -118.5 | |
| Changes by years, y/y, % | -34% | -12% | +18% | +17% | -30% | |||
| Changes by quarters, q/q, % | -35% | +69% | -19% | +32% | -62% | |||
